Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of leiteransu in HIV infection with chronic abnormal immune activation
CTR20221954Phase 2Active
- Sponsor
- Shanghai Pharmaceuticals Holding Co Ltd
- Start
- Aug 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxytriptolide in human immunodeficiency virus infection (HIV), sponsored by Shanghai Pharmaceuticals Holding Co Ltd. Started Aug 2022; status: active.
02
Drugs
hydroxytriptolide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on CTR20221954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221954.